Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2309 ARTÍCULOS , VIENDO DEL 1336 AL 1350

Prevalence and modifiable risk factors for dementia in persons with intellectual disabilities

Takenoshita S, Terada S, Inoue T, Kurozumi T, Yamada N, Kuwano R, Suemitsu S.

Alzheimers Res Ther. 2023 Jul 18;15(1):125. doi: 10.1186/s13195-023-01270-1.

Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons

Barnes LL, Dhana K, Liu X, Carey VJ, Ventrelle J, Johnson K, Hollings CS, Bishop L, Laranjo N, Stubbs BJ, Reilly X, Agarwal P, Zhang S, Grodstein F, Tangney CC, Holland TM, Aggarwal NT, Arfanakis K, Morris MC, Sacks FM.

N Engl J Med. 2023 Aug 17;389(7):602-611. doi: 10.1056/NEJMoa2302368. Epub 2023 Jul 18.

Diabetes-Alzheimer's connection in older age: SGLT2 inhibitors as promising modulators of disease pathways

Mancinetti F, Xenos D, De Fano M, Mazzieri A, Porcellati F, Boccardi V, Mecocci P.

Ageing Res Rev. 2023 Sep;90:102018. doi: 10.1016/j.arr.2023.102018. Epub 2023 Jul 20.

Quantification of identifying cognitive impairment using olfactory-stimulated functional near-infrared spectroscopy with machine learning: a post hoc analysis of a diagnostic trial and validation of an external additional trial

Kim J, Lee H, Lee J, Rhee SY, Shin JI, Lee SW, Cho W, Min C, Kwon R, Kim JG, Yon DK.

Alzheimers Res Ther. 2023 Jul 22;15(1):127. doi: 10.1186/s13195-023-01268-9.

Impact of Yoga Versus Memory Enhancement Training on Hippocampal Connectivity in Older Women at Risk for Alzheimer's Disease

Kilpatrick LA, Siddarth P, Krause-Sorio B, Milillo MM, Aguilar-Faustino Y, Ercoli L, Narr KL, Khalsa DS, Lavretsky H.

J Alzheimers Dis. 2023;95(1):149-159. doi: 10.3233/JAD-221159.

Identification of eating, drinking and swallowing difficulties for people living with early-stage dementia: A systematic review

O'Neill M, Duffy O, Henderson M, Kernohan WG.

Int J Lang Commun Disord. 2023 Nov-Dec;58(6):1994-2007. doi: 10.1111/1460-6984.12924. Epub 2023 Jul 22.

Cognitive Aspects of COVID-19

Gonzalez-Fernandez E, Huang J.

Curr Neurol Neurosci Rep. 2023 Sep;23(9):531-538. doi: 10.1007/s11910-023-01286-y. Epub 2023 Jul 25.

ChatGPT vs Google for Queries Related to Dementia and Other Cognitive Decline: Comparison of Results

Hristidis V, Ruggiano N, Brown EL, Ganta SRR, Stewart S.

J Med Internet Res. 2023 Jul 25;25:e48966. doi: 10.2196/48966.

White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS)

Eloyan A, Thangarajah M, An N, Borowski BJ, Reddy AL, Aisen P, Dage JL, Foroud T, Ghetti B, Griffin P, Hammers D, Iaccarino L, Jack CR Jr, Kirby K, Kramer J, Koeppe R, Kukull WA, La Joie R, Mundada NS, Murray ME, Nudelman K, Rumbaugh M, Soleimani-Meigooni DN, Toga A, Touroutoglou A, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez MF, Musiek E, Onyike CU, Rogalski E, Salloway S, Sha S, Turner RS, Wingo TS, Wolk DA, Womack K, Beckett L, Gao S, Carrillo MC, Rabinovici G, Apostolova LG, Dickerson B, Vemuri P; LEADS Consortium.

Alzheimers Dement. 2023 Nov;19 Suppl 9(Suppl 9):S89-S97. doi: 10.1002/alz.13402. Epub 2023 Jul 25.

Therapeutic dilemma's: antipsychotics use for neuropsychiatric symptoms of dementia, delirium and insomnia and risk of falling in older adults, a clinical review

Korkatti-Puoskari N, Tiihonen M, Caballero-Mora MA, Topinkova E, Szczerbińska K, Hartikainen S; on the Behalf of the EuGMS Task & Finish group on FRIDs.

Eur Geriatr Med. 2023 Aug;14(4):709-720. doi: 10.1007/s41999-023-00837-3. Epub 2023 Jul 26.

Effect of acupuncture on episodic memory for amnesia-type mild cognitive impairment: study protocol of a multicenter, randomized, controlled trial

Dai Y, Xia R, Wang D, Li S, Yuan X, Li X, Liu J, Wang M, Kuang Y, Chen S.

BMC Complement Med Ther. 2023 Jul 28;23(1):268. doi: 10.1186/s12906-023-04059-9.

Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus

Pelle MC, Zaffina I, Giofrè F, Pujia R, Arturi F.

Int J Mol Sci. 2023 Jul 11;24(14):11301. doi: 10.3390/ijms241411301.

Valproate-induced reversible cognitive decline presenting as dementia and associated clinical features: A literature review

Alsukhni RA, Johnson J, Nashef L.

Seizure. 2023 Oct;111:45-50. doi: 10.1016/j.seizure.2023.07.018. Epub 2023 Jul 25.

Role of Anemia in Dementia Risk Among Veterans With Incident CKD

Koyama AK, Nee R, Yu W, Choudhury D, Heng F, Cheung AK, Norris KC, Cho ME, Yan G.

Am J Kidney Dis. 2023 Dec;82(6):706-714. doi: 10.1053/j.ajkd.2023.04.013. Epub 2023 Jul 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias